Patent · US Expired

Thrombin receptor antagonists

US6894065B2 · kind B2 · utility

10Cited by
3References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 9, 2003
Grant dateMay 17, 2005
Priority date—
Expiry dateJun 9, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Heterocyclic-substituted compounds of the formula or a pharmaceutically acceptable salt thereof, are disclosed, wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.